AI-generated summary
The authors ran a double-blind, placebo-controlled trial of 66 patients with chronic cochlear tinnitus, comparing 650 nm low-level laser therapy with an inactive device over 4 weeks. They report no statistically significant differences between groups on tinnitus severity, self-rated loudness, or the Tinnitus Evaluation Test, concluding the laser was no better than placebo.
- Participants
- 66
- Who or what was studied
- Patients with chronic cochlear tinnitus (33 active laser, 33 inactive control)
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The abstract reports a single relatively small trial with 33 patients per group and does not describe long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Tinnitus, Laser, Placebo-controlled, Low-level laser therapy, Wavelength, Control group, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.